Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DOWN'S SYNDROME SCREENING MARKER LEVELS FOLLOWING ASSISTED REPRODUCTION

1 Dec 1996

Abstract excerpt

Maternal serum alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated oestriol (uE3) levels were examined in 1632 women who had ovulation induction and 327 who had in vitro fertilization. There was a highly statistically significant increase in hCG and reduction in uE3 among those with ovulation induction. The median levels were respectively 1.09 and 0.92 multiples of the normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 8994246
DOI: 10.1002/(sici)1097-0223(199612)16:12<1111::aid-pd998>3.0.co;2-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DOWN'S SYNDROME SCREENING MARKER LEVELS FOLLOWING ASSISTED REPRODUCTIONPMID 8994246Read ↗

Serum triple-marker screening in in vitro fertilization and naturally conceived pregnanciesSemantic proximity Read ↗

Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersSemantic proximity Read ↗

Appropriate biochemical parameters in first-trimester screening for Down syndromeSemantic proximity Read ↗

First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defectsSemantic proximity Read ↗

Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha‐fetoprotein, unconjugated oestriol, and human chorionic gonadotropinSemantic proximity Read ↗

Second trimester serum tests for Down's Syndrome screeningSemantic proximity Read ↗

Screening of Maternal Serum for Fetal Down's Syndrome in the First TrimesterSemantic proximity Read ↗

Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcomeSemantic proximity Read ↗

Second‐trimester double or triple screening for Down syndrome: A comparison of Chinese and Caucasian populationsSemantic proximity Read ↗

Predictive value of the triple screening test for the phenotype of Down syndrome.Semantic proximity Read ↗

Race-ethnicity-specific variation in multiple-marker biochemical screening: Alpha-fetoprotein, hCG, and EstriolSemantic proximity Read ↗

COMBINING INHIBIN A WITH EXISTING SECOND-TRIMESTER MARKERS IN MATERNAL SERUM SCREENING FOR DOWN'S SYNDROMESemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.